Clinical trial
Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine…
NCT00405964 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00405964 |
|---|---|
| Title | Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684) |
| Official title | Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Persistent Allergic Rhinitis (PER) |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | 5-mg Desloratadine, Placebo tablet |
| Enrollment | 716 |
| Start date | Sep 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Dec 4, 2006 |
| Last update posted | May 20, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: